GSKHGSK plc ADRhedged

Grow my money1y track recordRanked #2,214 of 2,960 in this goal

Seeks to provide investment results that correspond generally to the total return of the ordinary shares of GSK plc.

By ADRH · Launched 2025

Annual Cost

0.19%

#957 of 5,562 · low cost

Fund Size

$0.7M

#5,499 of 5,562 · small

Return (1Y)Goal

+34.3%

Track Record

1 year

#4,078 of 5,562 · young

Performance

Total-return NAV · USD

Growth of $10,000

$13,572+35.7%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

Europe

What it actually holds

By weight

Concentration

Top 3 holdings = 99.2% of fundconcentrated

GSK PLC

98.1%

DREYFUS TRSRY SECURITIES

0.9%

CANADIAN IMPERIAL BANK OF COMMERCE

0.2%

Asset allocation

Stocks

97.6%

Cash

2.4%

By sector

Healthcare

100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

26.2%High

Year-on-year price swings

Max drawdown

-18.5%Moderate

Worst peak-to-trough loss

Sharpe (3Y)

Unavailable

Needs 3+ years of history

Sortino (3Y)

Not yet

Needs 3+ years of history

Where to buy

Listing

Exchange: NYSE Arca

Full fund details

Objective: Seeks to provide investment results that correspond generally to the total return of the ordinary shares of GSK plc.
Strategy: Invests primarily in ADRs of GSK plc, maintaining at least 95% of net assets in these securities. Uses a currency swap to hedge against fluctuations in the exchange rate between the U.S. dollar and the British pound.
Inception date: January 6, 2025
Fund family: ADRH